Association AP, APA. (2010) Practice guidelines for the treatment of patients with major depressive disorder. Am Psychiatric Association. http://www.psychiatryonline.org/pb/assets/raw/sitewide/practice_guidelines/guidelines/mdd.pdf.
Kennedy SH, Lam RW, Mcintyre RS, Tourjman SV, Bhat V, Blier P, et al. Canadian Network for Mood and anxiety treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder. Can J Psychiatry. 2016;61(9):540–60.
Article PubMed PubMed Central Google Scholar
Malhi GS, Bell E, Bassett D, Boyce P, Bryant R, Hazell P, et al. The 2020 Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders. Australian & New Zealand Journal of Psychiatry. 2021;55(1):7–117.
[NG222] Ng. Depression in adults: treatment and management [Available from: https://www.nice.org.uk/guidance/ng222.
Cipriani A, Furukawa TA, Salanti G, Chaimani A, Atkinson LZ, Ogawa Y, et al. Comparative efficacy and acceptability of 21 antidepressant Drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. The Lancet. 2018;391(10128):1357–66.
Duodecim TFMS, Working group set up by the Finnish Medical Society Duodecim and the Finnish Psychiatric Association. Depression. Current Care Guidelines. Helsinki: The Finnish Medical Society Duodecim, 2022 (referred 13.2.2023). Available online at: www.kaypahoito.fi.
Gaynes BN, Lux L, Gartlehner G, Asher G, Forman-Hoffman V, Green J, et al. Defining treatment‐resistant Depression Depression and Anxiety. 2020;37(2):134–45.
Gaynes BN, Rush AJ, Trivedi MH, Wisniewski SR, Spencer D, Fava M. The STAR*D study: treating depression in the real world. Cleve Clin J Med. 2008;75(1):57–66.
Gaynes BN, Dusetzina SB, Ellis AR, Hansen RA, Farley JF, Miller WC, et al. Treating Depression after initial treatment failure: directly comparing switch and augmenting strategies in STAR*D. J Clin Psychopharmacol. 2012;32(1):114–9.
Henssler J, Alexander D, Schwarzer G, Bschor T, Baethge C. Combining antidepressants vs antidepressant monotherapy for treatment of patients with Acute Depression. JAMA Psychiatry. 2022;79(4):300–12.
Article PubMed PubMed Central Google Scholar
Mishra A, Sarangi SC, Maiti R, Sood M, Reeta K. Efficacy and safety of adjunctive serotonin-dopamine activity modulators in Major Depression: a Meta‐Analysis of Randomized controlled trials. J Clin Pharmacol. 2022;62(6):721–32.
Article CAS PubMed Google Scholar
Scott F, Hampsey E, Gnanapragasam S, Carter B, Marwood L, Taylor RW et al. Systematic review and meta-analysis of augmentation and combination treatments for early-stage treatment-resistant depression. J Psychopharmacol. 2022;2698811221104058.
Taylor RW, Marwood L, Oprea E, DeAngel V, Mather S, Valentini B, et al. Pharmacological augmentation in Unipolar Depression: a guide to the guidelines. Int J Neuropsychopharmacol. 2020;23(9):587–625.
Article PubMed PubMed Central Google Scholar
Vázquez GH, Bahji A, Undurraga J, Tondo L, Baldessarini RJ. Efficacy and tolerability of combination treatments for Major Depression: antidepressants plus Second-Generation antipsychotics vs. esketamine vs. Lithium J Psychopharmacol. 2021;35(8):890–900.
De Carlo V, Calati R, Serretti A. Socio-demographic and clinical predictors of non-response/non-remission in treatment resistant depressed patients: a systematic review. Psychiatry Res. 2016;240:421–30.
Perlman K, Benrimoh D, Israel S, Rollins C, Brown E, Tunteng J-F, et al. A systematic meta-review of predictors of antidepressant treatment outcome in major depressive disorder. J Affect Disord. 2019;243:503–15.
Article CAS PubMed Google Scholar
Simon GE, Perlis RH. Personalized Medicine for Depression: can we Match patients with treatments? Am J Psychiatry. 2010;167(12):1445–55.
Article PubMed PubMed Central Google Scholar
Trivedi MH. Tools and strategies for Ongoing Assessment of Depression. J Clin Psychiatry. 2009;70(suppl 6):26–31.
Xiao L, Qi H, Zheng W, Xiang Y-T, Carmody TJ, Mayes TL, et al. The effectiveness of enhanced evidence-based care for depressive disorders: a meta-analysis of randomized controlled trials. Translational Psychiatry. 2021;11(1):531.
Article PubMed PubMed Central Google Scholar
Zhu M, Hong RH, Yang T, Yang X, Wang X, Liu J, et al. The efficacy of measurement-based Care for Depressive disorders. J Clin Psychiatry. 2021;82(5):21r14034.
Guo T, Xiang Y-T, Xiao L, Hu C-Q, Chiu HFK, Ungvari GS, et al. Measurement-based Care Versus Standard Care for Major Depression: a Randomized Controlled Trial with Blind Raters. Am J Psychiatry. 2015;172(10):1004–13.
Duhoux A, Fournier L, Nguyen CT, Roberge P, Beveridge R. Guideline concordance of treatment for depressive disorders in Canada. Soc Psychiatry Psychiatr Epidemiol. 2009;44(5):385–92.
Fernández A, Haro Jm Fau - Codony M, Codony M, Fau - Vilagut G, Vilagut G, Fau - Martínez-Alonso M, Martínez-Alonso MF, Autonell J, Autonell JF, Salvador-Carulla L, et al. Treatment adequacy of anxiety and depressive disorders: primary versus specialised care in Spain. J Affect Disord. 2006;96(1–2):9–20.
Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR, et al. The epidemiology of major depressive disorder. JAMA. 2003;289(23):3095–105.
Lisinski A, Hieronymus F, Eriksson E, Wallerstedt SM. Low SSRI dosing in clinical practice—a register-based longitudinal study. Acta Psychiatrica Scandinavica. 2021;143(5):434–43.
Article CAS PubMed Google Scholar
Schneider F, Kratz S, Bermejo I, Menke R, Mulert C, Hegerl U, et al. Insufficient depression treatment in outpatient settings. Ger Med Sci. 2004;2:Doc01.
PubMed PubMed Central Google Scholar
Simon GE, Von Korff M, Rutter CM, Peterson DA. Treatment process and outcomes for Managed Care patients receiving New Antidepressant prescriptions from psychiatrists and Primary Care Physicians. Arch Gen Psychiatry. 2001;58(4):395–401.
Article CAS PubMed Google Scholar
Thornicroft G, Chatterji S, Evans-Lacko S, Gruber M, Sampson N, Aguilar-Gaxiola S, et al. Undertreatment of people with major depressive disorder in 21 countries. Br J Psychiatry. 2017;210(2):119–24.
Article PubMed PubMed Central Google Scholar
Vigo D, Haro JM, Hwang I, Aguilar-Gaxiola S, Alonso J, Borges G, et al. Toward measuring effective treatment coverage: critical bottlenecks in quality- and user-adjusted coverage for major depressive disorder. Psychol Med. 2022;52(10):1948–58.
Mojtabai R, Amin-Esmaeili M, Spivak S, Olfson M. Remission and treatment augmentation of Depression in the United States. J Clin Psychiatry. 2021;82(6):21m13988.
Herzog DP, Wagner S, Ruckes C, Tadic A, Roll SC, Härter M, et al. Guideline adherence of antidepressant treatment in outpatients with major depressive disorder: a naturalistic study. Eur Arch Psychiatry Clin NeuroSci. 2017;267(8):711–21.
Gaynes BN, Rush AJ, Trivedi M, Wisniewski SR, Balasubramani GK, Spencer DC, et al. A direct comparison of presenting characteristics of depressed outpatients from primary vs. specialty care settings: preliminary findings from the STAR*D clinical trial. Gen Hosp Psychiatry. 2005;27(2):87–96.
Gaynes BN, Rush AJ, Trivedi MH, Wisniewski SR, Balasubramani GK, Spencer DC, et al. Major depression symptoms in Primary Care and Psychiatric Care settings: a cross-sectional analysis. The Annals of Family Medicine. 2007;5(2):126–34.
Castro-Rodríguez JI, Olariu E, Garnier-Lacueva C, Martín-López LM, Pérez-Solà V, Alonso J, et al. Diagnostic accuracy and adequacy of treatment of depressive and anxiety disorders: a comparison of primary care and specialized care patients. J Affect Disord. 2015;172:462–71.
Gabilondo A, Rojas-Farreras S, Rodráguez A, Ferníndez A, Pinto-Meza A, Vilagut G, et al. Use of primary and specialized Mental Health Care for a major depressive episode in Spain by ESEMeD respondents. Psychiatric Serv. 2011;62(2):152–61.
Wang PS, Lane M, Olfson M, Pincus HA, Wells KB, Kessler RC. Twelve-Month Use of Mental Health Services in the United States. Arch Gen Psychiatry. 2005;62(6):629–40.
Kasteenpohja T, Marttunen M, Aalto-Setälä T, Perälä J, Saarni SI, Suvisaari J. Treatment received and treatment adequacy of depressive disorders among young adults in Finland. BMC Psychiatry. 2015;15(1):47.
Article PubMed PubMed Central Google Scholar
Melartin TK, Rytsälä HJ, Leskelä US, Lestelä-Mielonen PS, Sokero TP, Isometsä ET. Continuity is the main challenge in treating major depressive disorder in psychiatric care. J Clin Psychiatry. 2005;66:220–7.
Rytsälä HJ, Melartin MD, Leskelä TKMD, US MA, Lestelä-Mielonen PS, Sokero MAT, Isometsä PMD. ET, M.D., Ph.D. A Record-Based Analysis of 803 Patients Treated for Depression in Psychiatric Care. J Clin Psychiatry. 2001;62:701-6.
Vuorilehto MS, Melartin TK, Rytsälä HJ, Isometsä ET. Do characteristics of patients with major depressive disorder differ between primary and psychiatric care? Psychol Med. 2007;37(6):893–904.
Lähteenvuo M, Taipale H, Tanskanen A, Rannanpää S, Tiihonen J. Courses of treatment and risk factors for treatment-resistant depression in Finnish primary and special healthcare: a nationwide cohort study. J Affect Disord. 2022;308:236–42.
Linnaranta O. Selvitys psykiatristen sairaalapaikkojen määrästä. Terveyden ja hyvinvoinnin laitos THL; 2022. https://urn.fi/URN:ISBN:978-952-343-820-0.
WHO. World Health Organization. International classification of Disease. 10th ed. Geneva: WHO; 1992.
Kroenk
Comments (0)